Mei Pharma logo

Mei Pharma share price today

(MEIP)

Mei Pharma share price is $2.68 & ₹229.97 as on 7 Jan 2025, 2.30 'hrs' IST

$2.68

Market is closed - opens 8 PM, 07 Jan 2025

View live Mei Pharma share price in Dollar and Rupees. Guide to invest in Mei Pharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Mei Pharma, along with analyst recommendations, forecasts, and comprehensive financials.

Mei Pharma share price movements

  • Today's Low: $2.61
    Today's High: $2.77

    Day's Volatility :5.78%

  • 52 Weeks Low: $2.30
    52 Weeks High: $6.26

    52 Weeks Volatility :63.26%

Mei Pharma Returns

PeriodMei Pharma IncIndex (Russel 2000)
3 Months
-1.11%
0.0%
6 Months
-4.63%
0.0%
1 Year
-53.39%
0.0%
3 Years
-94.64%
-19.8%

Mei Pharma Key Statistics

in dollars & INR

Previous Close
$2.68
Open
$2.65
Today's High
$2.77
Today's Low
$2.61
Market Capitalization
$17.9M
Today's Volume
$26.3K
52 Week High
$6.26
52 Week Low
$2.3
Revenue TTM
$65.3M
EBITDA
$26.4M
Earnings Per Share (EPS)
$-6.99
Profit Margin
27.23%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
61.68%

How to invest in Mei Pharma from India?

It is very easy for Indian residents to invest directly in Mei Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Mei Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Mei Pharma or MEIP on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Mei Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Mei Pharma shares which would translate to 0.320 fractional shares of Mei Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Mei Pharma, in just a few clicks!

Returns in Mei Pharma for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Mei Pharma investment value today

Current value as on today

₹49,831

Returns

₹50,169

(-50.17%)

Returns from Mei Pharma Stock

₹53,391 (-53.39%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Mei Pharma

156%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Mei Pharma on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 156% more investors are searching Mei Pharma in the last 30 days versus the previous period.

Global Institutional Holdings in Mei Pharma

  • Anson Funds Management LP

    16.41%

  • Cable Car Capital LLC

    9.18%

  • Vanguard Group Inc

    5.79%

  • Renaissance Technologies Corp

    2.07%

  • BlackRock Inc

    1.12%

  • Geode Capital Management, LLC

    0.89%

Analyst Recommendation on Mei Pharma

Buy

    77%Buy

    22%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Mei Pharma(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
7
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Mei Pharma

What analysts predicted

Upside of 646.27%

Current:

$2.68

Target:

$20.00

Insights on Mei Pharma

  • Price Movement

    In the last 3 years, MEIP stock has moved down by -95.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.45M → 65.29M (in $), with an average increase of 97.8% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -18.40M → -8.00M (in $), with an average increase of 129.9% per quarter
  • MEIP vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 78.4%
  • MEIP vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 150.2%
  • Price to Sales

    ForMEIP every $1 of sales, investors are willing to pay $0.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Mei Pharma Technicals Summary

Sell

Neutral

Buy

Mei Pharma is currently in a neutral trading position according to technical analysis indicators.

Mei Pharma Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Mei Pharma Inc
-4.29%
-4.63%
-53.39%
-94.64%
-93.43%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Mei Pharma Inc
1.08
NA
20.6
0.0
0.62
0.2
NA
4.96
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Mei Pharma Inc
Buy
$17.9M
-93.43%
1.08
27.23%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Mei Pharma

mei pharma (nasdaq: meip) is a san diego-based oncology company focused on the clinical development of novel therapies for cancer. our lead drug candidate is pracinostat, a potential best-in-class, oral hdac inhibitor that has been granted breakthrough therapy designation from the fda in combination with azacitidine for the treatment of patients with newly diagnosed aml who are ≥75 years of age or unfit for intensive chemotherapy. our pipeline of drug candidates also includes me-401 (formerly pwt143), a next-generation oral pi3k delta inhibitor, and me-344, a novel mitochondrial inhibitor. for more, please go to www.meipharma.com.
Organization
Mei Pharma
Employees
28
CEO
Ms. Yomara Gomez-Naiden
Industry
Health Technology

Management People of Mei Pharma

NameTitle
Ms. Yomara Gomez-Naiden
Senior Vice President of Operations & Quality
Ms. Nicole Chyoko Iida
Vice President of Legal Affairs
Ms. Anne Frese
Chief People Officer
Dr. Robert D. Mass
Strategic Advisor
Mr. David A. Walsey J.D., L.L.M.
Senior Vice President of Corporate Affairs

Important FAQs about investing in Mei Pharma from India :

What is Mei Pharma share price today?

Mei Pharma share price today stands at $2.68, Open: $2.65 ; Previous Close: $2.68 ; High: $2.77 ; Low: $2.61 ; 52 Week High: $6.26 ; 52 Week Low: $2.30. The stock opens at $2.65, after a previous close of $2.68. The stock reached a daily high of $2.77 and a low of $2.61, with a 52-week high of $6.26 and a 52-week low of $2.30.

Can Indians buy Mei Pharma shares?

Yes, Indians can invest in the Mei Pharma (MEIP) from India.

With INDmoney, you can buy Mei Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Mei Pharma at zero transaction cost.

How can I buy Mei Pharma shares from India?

It is very easy to buy Mei Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Mei Pharma be purchased?

Yes, you can buy fractional shares of Mei Pharma with INDmoney app.

What are the documents required to start investing in Mei Pharma stocks?

To start investing in Mei Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Mei Pharma

Today’s highest price of Mei Pharma (MEIP) is $2.77.

Today’s lowest price of Mei Pharma (MEIP) is $2.61.

What is today's market capitalisation of Mei Pharma

Today's market capitalisation of Mei Pharma MEIP is 17.9M

What is the 52 Week High and Low Range of Mei Pharma

  • 52 Week High

    $6.26

  • 52 Week Low

    $2.30

What are the historical returns of Mei Pharma?

  • 1 Month Returns

    -4.29%

  • 3 Months Returns

    -4.63%

  • 1 Year Returns

    -53.39%

  • 5 Years Returns

    -93.43%

Who is the Chief Executive Officer (CEO) of Mei Pharma

Ms. Yomara Gomez-Naiden is the current Chief Executive Officer (CEO) of Mei Pharma.